Prognostic Factors, Treatment, and Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab (R) Era

被引：0
|
作者：
Hiniker, S. M. [1 ]
Pollom, E. L. [1 ]
Khodadoust, M. S. [1 ]
Kozak, M. M. [1 ]
Advani, R. H. [1 ]
Hoppe, R. T. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2014年 / 90卷
关键词：
D O I：
10.1016/j.ijrobp.2014.05.1993
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3185
引用
收藏
页码：S677 / S678
页数：2
相关论文
共 50 条
  • [1] Outcomes of cardiac diffuse large B-cell lymphoma (DLBCL) in the rituximab era
    Al-Juhaishi, Taha
    Al-Kindi, Sadeer G.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 339 : 146 - 149
  • [2] Limited-stage diffuse large B-cell lymphoma
    Hawkes, Eliza A.
    Barraclough, Allison
    Sehn, Laurie H.
    BLOOD, 2022, 139 (06) : 822 - 834
  • [3] Does Limited-Stage Diffuse Large B-Cell Lymphoma (LS-DLBCL) Matter?
    Martynchyk, Arina
    Hawkes, Eliza A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S44 - S46
  • [4] Radioimmunotherapy in limited-stage diffuse large B-cell lymphoma
    Miao, Yi
    Fan, Lei
    Li, Jianyong
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 (01) : 83 - 84
  • [5] Prognostic factors for diffuse large B-cell lymphoma: clinical and biological factors in the rituximab era
    Liang, Xiping
    Hu, Renzhi
    Li, Qiying
    Wang, Chaoyu
    Liu, Yao
    EXPERIMENTAL HEMATOLOGY, 2023, 122 : 1 - 9
  • [6] Diffuse large B cell lymphoma: prognostic factors in the rituximab era
    Guevara Arismendy, Natalia Maria
    Jaramillo Arbelaez, Patricia Elena
    Gaviria Jaramillo, Lina Maria
    IATREIA, 2013, 26 (03) : 302 - 312
  • [7] Survival Outcomes of Limited-Stage Diffuse Large B-Cell Lymphoma Treated With Radiation Therapy
    Ermann, Daniel A.
    Vardell, Victoria A.
    Shah, Harsh
    Fitzgerald, Lindsey
    Tao, Randa
    Gaffney, David K.
    Stephens, Deborah M.
    Hu, Boyu
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 (02): : 94 - 104.e6
  • [8] Outcomes of de novo CD5+diffuse large b-cell lymphoma (DLBCL) in the rituximab (R) era.
    Hu, Bei
    Loghavi, Sanam
    Fayad, Luis
    Noorani, Mansoor
    Fowler, Nathan Hale
    Hagemeister, Fredrick B.
    Lee, Hun Ju
    Nastoupil, Loretta J.
    Neelapu, Sattva Swarup
    Fanale, Michelle A.
    Samaniego, Felipe
    Turturro, Francesco
    Wang, Michael
    Davis, Richard Eric
    Westin, Jason R.
    Medeiros, L. Jeffrey
    Oki, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Outcomes of Cardiac Diffuse Large B-Cell Lymphoma in the Rituximab Era
    Al-Juhaishi, Taha
    Abu Zeinah, Ghaith
    Al-Kindi, Sadeer
    BLOOD, 2020, 136
  • [10] Outcomes of limited stage primary bone diffuse large B-cell lymphoma in the rituximab era: a multicenter, retrospective study
    Rezazadeh, Alexandra
    Szabo, Aniko
    Khurana, Arushi
    Inwards, David J.
    Lunning, Matthew A.
    Bartlett, Nancy L.
    Caimi, Paolo F.
    Rodgers, Thomas D.
    Barr, Paul M.
    Chowdhury, Sayan Mullick
    Epperla, Narendranath
    Mendries, Hiruni
    Hill, Brian T.
    Oh, Timothy S.
    Karmali, Reem
    Chang, Julie E.
    Goyal, Gaurav
    Parsons, Benjamin M.
    Isaac, Krista M.
    Portell, Craig A.
    Monahan, Kathleen
    Siker, Malika
    King, David M.
    Fenske, Timothy S.
    HAEMATOLOGICA, 2024, 109 (05) : 1439 - 1444
12345